Management of Bleeding Patients
Samenvatting
This latest edition provides a comprehensive, state-of-the-art overview of the major issues specific to managing bleeding patients. Like the previous edition, the sections of this new edition have been structured to review the overall scope of issues, among them bleeding associated with disease condition, bleeding from specific organs, bleeding associated with medication, and bleeding associated with procedures. In addition to thoroughly revised and updated chapters from the previous edition, the latest edition features new chapters on such topics as the basics of hemostasis, bleeding due to rare coagulation factor deficiencies, bleeding associated with connective tissue disorders, massive transfusion protocol, bleeding associated with ventricular assist device, and evaluation of bleeding risk prior to invasive procedures. The volume also includes brief etiology and a practical reference guide regarding type of blood components, medication, dose, and duration.
Written by authors from a variety of integrated disciplines, Management of Bleeding Patients, Second Edition is a valuable resource for clinicians working in the area of bleeding management.
Specificaties
Inhoudsopgave
<p>II: BLEEDING ASSOCIATED WITH DISEASE CONDITION</p><p>8. Known Bleeding Disorders for Surgery</p><p>9. Hemophilia A, Hemophilia B, Congenital von Willebrand Disease, and Acquired von Willebrand Syndrome</p>
<p>10. Bleeding Associated with Coagulation Factor Inhibitors</p><p>11. Bleeding Due to Rare Coagulation Factor Deficiencies</p>12. Pregnancy-Associated Bleeding<p></p><p>13. Bleeding Associated with Thrombocytopenia</p><p>14. Bleeding in Acute and Chronic Liver Disease</p><p>15. Bleeding and Hyperfibrinolysis</p><p>16. Bleeding of Unknown Etiology</p><p>17. Bleeding Associated with Disseminated Intravascular Coagulation</p><p>18. Bleeding and Vitamin K Deficiency</p><p>19. Bleeding in Uremia</p><p>20. Bleeding Associated with Connective Tissue Disorders</p><p>21. Bleeding Associated with Trauma</p><p>22. Massive Transfusion Protocol</p><p>23. Lupus Anticoagulant Hypoprothrombinemia Syndrome (LAHPS)</p><p>III: BLEEDING FROM SPECIFIC ORGANS</p><p>24. Intracerebral Hemorrhage: An Overview of Etiology, Pathophysiology, Clinical Presentation, and Advanced Treatment Strategies</p><p>25. Epistaxis</p>26. Bleeding Disorders Related to Lung Disease<p></p><p>27. Heavy Menstrual Bleeding</p><p>28. Gross Hematuria</p><p>29. Upper Gastrointestinal Bleeding</p>
<p>IV: BLEEDING ASSOCIATED WITH MEDICATION</p><p>30. Antiplatelet and Anticoagulant Agents</p><p>31. Thrombolytic Therapy: tPA-Induced Bleeding</p>
<p>V: BLEEDING ASSOCIATED WITH PROCEDURE</p>32. Bleeding Associated with ECMO<p></p><p>33. Management of Bleeding Associated with Durable Mechanical Circulatory Support</p><p>34. Bleeding Related to Cardiac Surgery </p><p>35. Bleeding Related to Liver Transplant</p><p>36. Percutaneous Image-Guided Interventions Including Solid Organ Biopsies</p><p>37. Dental Extractions in Patients with Congenital and Acquired Bleeding Disorders</p>
VI: SPECIFIC ISSUES IN NEONATES AND PEDIATRICS<p></p><p>38. Neonatal Thrombocytopenia</p><p>39. Bleeding in the Neonate</p>
<p>VII: EVALUATION OF BLEEDING RISK PRIOR TO INVASIVE PROCEDURES</p><p>40. Evaluation of Bleeding Risk Prior to Pediatric Invasive Procedures</p><p>41. Evaluation of Bleeding Risk Prior to Invasive Procedures</p>
<p>VIII: HEMOSTATIC AGENTS AND BLOOD COMPONENTS USED TO STOP BLEEDING</p><p>42. Hemostatic Agents and Blood Components Used to Stop Bleeding</p><p>43. Blood Components</p>
<p><br></p><br>